APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artemisinin and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artemisinin and Derivatives Market Analysis and Forecast 2026-2032

23 December 2025203 pages

Choose your research edition.

Industry ResearchArtemisinin and Derivatives Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Artemisinin and Derivatives Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Artemisinin and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artemisinin and Derivatives Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Artemisinin and Derivatives Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Artemisinin and Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Artemisinin and Derivatives's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Ipca Laboratories as the global sales leader, a title it has maintained for several consecutive years. Notably, Ipca Laboratories's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Artemisinin and Derivatives market include Ipca Laboratories, Guilin Nantang Pharmaceutical, KPC Pharmaceuticals, Chongqing Kerui Nanhai Pharmaceutical, Sichuan Xieli Pharmaceutical, Cerata Pharmaceuticals and Aqre Group, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Artemisinin and Derivatives production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Artemisinin and Derivatives by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Artemisinin and Derivatives, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artemisinin and Derivatives, also provides the consumption of main regions and countries. Of the upcoming market potential for Artemisinin and Derivatives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artemisinin and Derivatives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artemisinin and Derivatives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Artemisinin and Derivatives sales, projected growth trends, production technology, application and end-user industry.

Artemisinin and Derivatives Segment by Company

Ipca Laboratories

Guilin Nantang Pharmaceutical

KPC Pharmaceuticals

Chongqing Kerui Nanhai Pharmaceutical

Sichuan Xieli Pharmaceutical

Cerata Pharmaceuticals

Aqre Group

Artemisinin and Derivatives Segment by Type

Artemether

Artesunate

Artemisinin

Dihydroartemisinin

Artemisinin and Derivatives Segment by Application

Antitumor and Anti-inflammatory Drugs

Antimalarial Drugs

Artemisinin and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artemisinin and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artemisinin and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artemisinin and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Artemisinin and Derivatives production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Artemisinin and Derivatives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Artemisinin and Derivatives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artemisinin and Derivatives sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artemisinin and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Artemether Major Manufacturers Table 3. Artesunate Major Manufacturers Table 4. Artemisinin Major Manufacturers Table 5. Dihydroartemisinin Major Manufacturers Table 6. Global Artemisinin and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Antitumor and Anti-inflammatory Drugs Major Manufacturers Table 8. Antimalarial Drugs Major Manufacturers Table 9. Artemisinin and Derivatives Industry Trends Table 10. Artemisinin and Derivatives Industry Drivers Table 11. Artemisinin and Derivatives Industry Opportunities and Challenges Table 12. Artemisinin and Derivatives Industry Restraints Table 13. Global Artemisinin and Derivatives Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 14. Global Artemisinin and Derivatives Production by Region (2021-2026) & (Tons) Table 15. Global Artemisinin and Derivatives Production by Region (2027-2032) & (Tons) Table 16. Global Artemisinin and Derivatives Production Market Share by Region (2021-2026) Table 17. Global Artemisinin and Derivatives Production Market Share by Region (2027-2032) Table 18. Global Artemisinin and Derivatives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Artemisinin and Derivatives Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Artemisinin and Derivatives Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Artemisinin and Derivatives Revenue Market Share by Region (2021-2026) Table 22. Global Artemisinin and Derivatives Revenue Market Share by Region (2027-2032) Table 23. Global Artemisinin and Derivatives Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 24. Global Artemisinin and Derivatives Sales by Region (2021-2026) & (Tons) Table 25. Global Artemisinin and Derivatives Sales by Region (2027-2032) & (Tons) Table 26. Global Artemisinin and Derivatives Sales Market Share by Region (2021-2026) Table 27. Global Artemisinin and Derivatives Sales Market Share by Region (2027-2032) Table 28. Global Artemisinin and Derivatives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Artemisinin and Derivatives Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Artemisinin and Derivatives Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Artemisinin and Derivatives Sales Market Share by Manufacturers (2021-2026) Table 32. Global Artemisinin and Derivatives Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 33. Global Artemisinin and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Artemisinin and Derivatives Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Artemisinin and Derivatives Manufacturers, Product Type & Application Table 36. Global Artemisinin and Derivatives Manufacturers Commercialization Time Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Artemisinin and Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 39. Global Artemisinin and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Artemisinin and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Artemisinin and Derivatives Revenue Market Share by Type (2021-2026) Table 42. Global Artemisinin and Derivatives Revenue Market Share by Type (2027-2032) Table 43. Global Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 44. Global Artemisinin and Derivatives Sales by Type (2027-2032) & (Tons) Table 45. Global Artemisinin and Derivatives Sales Market Share by Type (2021-2026) Table 46. Global Artemisinin and Derivatives Sales Market Share by Type (2027-2032) Table 47. Global Artemisinin and Derivatives Price by Type (2021-2026) & (US$/Ton) Table 48. Global Artemisinin and Derivatives Price by Type (2027-2032) & (US$/Ton) Table 49. Global Artemisinin and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Artemisinin and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Artemisinin and Derivatives Revenue Market Share by Application (2021-2026) Table 52. Global Artemisinin and Derivatives Revenue Market Share by Application (2027-2032) Table 53. Global Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 54. Global Artemisinin and Derivatives Sales by Application (2027-2032) & (Tons) Table 55. Global Artemisinin and Derivatives Sales Market Share by Application (2021-2026) Table 56. Global Artemisinin and Derivatives Sales Market Share by Application (2027-2032) Table 57. Global Artemisinin and Derivatives Price by Application (2021-2026) & (US$/Ton) Table 58. Global Artemisinin and Derivatives Price by Application (2027-2032) & (US$/Ton) Table 59. Ipca Laboratories Company Information Table 60. Ipca Laboratories Business Overview Table 61. Ipca Laboratories Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 62. Ipca Laboratories Artemisinin and Derivatives Product Portfolio Table 63. Ipca Laboratories Recent Development Table 64. Guilin Nantang Pharmaceutical Company Information Table 65. Guilin Nantang Pharmaceutical Business Overview Table 66. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 67. Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 68. Guilin Nantang Pharmaceutical Recent Development Table 69. KPC Pharmaceuticals Company Information Table 70. KPC Pharmaceuticals Business Overview Table 71. KPC Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 72. KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio Table 73. KPC Pharmaceuticals Recent Development Table 74. Chongqing Kerui Nanhai Pharmaceutical Company Information Table 75. Chongqing Kerui Nanhai Pharmaceutical Business Overview Table 76. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 77. Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 78. Chongqing Kerui Nanhai Pharmaceutical Recent Development Table 79. Sichuan Xieli Pharmaceutical Company Information Table 80. Sichuan Xieli Pharmaceutical Business Overview Table 81. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 82. Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio Table 83. Sichuan Xieli Pharmaceutical Recent Development Table 84. Cerata Pharmaceuticals Company Information Table 85. Cerata Pharmaceuticals Business Overview Table 86. Cerata Pharmaceuticals Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 87. Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio Table 88. Cerata Pharmaceuticals Recent Development Table 89. Aqre Group Company Information Table 90. Aqre Group Business Overview Table 91. Aqre Group Artemisinin and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 92. Aqre Group Artemisinin and Derivatives Product Portfolio Table 93. Aqre Group Recent Development Table 94. North America Artemisinin and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Artemisinin and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 97. North America Artemisinin and Derivatives Sales by Type (2027-2032) & (Tons) Table 98. North America Artemisinin and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 99. North America Artemisinin and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 100. North America Artemisinin and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Artemisinin and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 103. North America Artemisinin and Derivatives Sales by Application (2027-2032) & (Tons) Table 104. North America Artemisinin and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 105. North America Artemisinin and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 106. North America Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Artemisinin and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. North America Artemisinin and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. North America Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 110. North America Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 111. North America Artemisinin and Derivatives Sales by Country (2027-2032) & (Tons) Table 112. North America Artemisinin and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 113. North America Artemisinin and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 114. United States Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 115. Canada Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 116. Mexico Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 117. Europe Artemisinin and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Artemisinin and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 120. Europe Artemisinin and Derivatives Sales by Type (2027-2032) & (Tons) Table 121. Europe Artemisinin and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 122. Europe Artemisinin and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 123. Europe Artemisinin and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Artemisinin and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 126. Europe Artemisinin and Derivatives Sales by Application (2027-2032) & (Tons) Table 127. Europe Artemisinin and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 128. Europe Artemisinin and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 129. Europe Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Artemisinin and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. Europe Artemisinin and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. Europe Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 133. Europe Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 134. Europe Artemisinin and Derivatives Sales by Country (2027-2032) & (Tons) Table 135. Europe Artemisinin and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 136. Europe Artemisinin and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 137. Germany Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 138. France Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 139. U.K. Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 140. Italy Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 141. Russia Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 142. Spain Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 143. Netherlands Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 144. Switzerland Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 145. Sweden Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 146. Poland Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 147. China Artemisinin and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 148. China Artemisinin and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 149. China Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 150. China Artemisinin and Derivatives Sales by Type (2027-2032) & (Tons) Table 151. China Artemisinin and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 152. China Artemisinin and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 153. China Artemisinin and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 154. China Artemisinin and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 155. China Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 156. China Artemisinin and Derivatives Sales by Application (2027-2032) & (Tons) Table 157. China Artemisinin and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 158. China Artemisinin and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 159. Asia Artemisinin and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 160. Asia Artemisinin and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 161. Asia Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 162. Asia Artemisinin and Derivatives Sales by Type (2027-2032) & (Tons) Table 163. Asia Artemisinin and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 164. Asia Artemisinin and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 165. Asia Artemisinin and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 166. Asia Artemisinin and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 167. Asia Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 168. Asia Artemisinin and Derivatives Sales by Application (2027-2032) & (Tons) Table 169. Asia Artemisinin and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 170. Asia Artemisinin and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 171. Asia Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. Asia Artemisinin and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. Asia Artemisinin and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. Asia Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 175. Asia Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 176. Asia Artemisinin and Derivatives Sales by Country (2027-2032) & (Tons) Table 177. Asia Artemisinin and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 178. Asia Artemisinin and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 179. Japan Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 180. South Korea Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 181. India Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 182. Australia Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 183. Taiwan Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 184. Southeast Asia Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 185. SAMEA Artemisinin and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 186. SAMEA Artemisinin and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 187. SAMEA Artemisinin and Derivatives Sales by Type (2021-2026) & (Tons) Table 188. SAMEA Artemisinin and Derivatives Sales by Type (2027-2032) & (Tons) Table 189. SAMEA Artemisinin and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 190. SAMEA Artemisinin and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 191. SAMEA Artemisinin and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 192. SAMEA Artemisinin and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 193. SAMEA Artemisinin and Derivatives Sales by Application (2021-2026) & (Tons) Table 194. SAMEA Artemisinin and Derivatives Sales by Application (2027-2032) & (Tons) Table 195. SAMEA Artemisinin and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 196. SAMEA Artemisinin and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 197. SAMEA Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 198. SAMEA Artemisinin and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 199. SAMEA Artemisinin and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 200. SAMEA Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 201. SAMEA Artemisinin and Derivatives Sales by Country (2021-2026) & (Tons) Table 202. SAMEA Artemisinin and Derivatives Sales by Country (2027-2032) & (Tons) Table 203. SAMEA Artemisinin and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 204. SAMEA Artemisinin and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 205. Brazil Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 206. Argentina Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 207. Chile Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 208. Colombia Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 209. Peru Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 210. Saudi Arabia Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 211. Israel Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 212. UAE Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 213. Turkey Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 214. Iran Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 215. Egypt Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. Artemisinin and Derivatives Distributors List Table 219. Artemisinin and Derivatives Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. Artemisinin and Derivatives Product Image Figure 2. Global Artemisinin and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artemisinin and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure . Artemether Image Figure 1. Artesunate Image Figure 2. Artemisinin Image Figure 3. Dihydroartemisinin Image Figure 4. Global Artemisinin and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 5. Global Artemisinin and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure 6. Antitumor and Anti-inflammatory Drugs Image Figure 7. Antimalarial Drugs Image Figure 8. Global Artemisinin and Derivatives Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 9. Global Artemisinin and Derivatives Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 10. Global Artemisinin and Derivatives Production Market Share by Region: 2025 Versus 2032 Figure 11. Global Artemisinin and Derivatives Production Market Share by Region (2021-2032) Figure 12. North America Artemisinin and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 13. Europe Artemisinin and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 14. China Artemisinin and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 15. Japan Artemisinin and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 16. Global Artemisinin and Derivatives Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Artemisinin and Derivatives Revenue (2021-2032) & (US$ Million) Figure 18. Global Artemisinin and Derivatives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Artemisinin and Derivatives Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Artemisinin and Derivatives Revenue Market Share by Region (2021-2032) Figure 21. Global Artemisinin and Derivatives Sales (2021-2032) & (Tons) Figure 22. Global Artemisinin and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 23. Global Artemisinin and Derivatives Sales Market Share by Region (2021-2032) Figure 24. North America Artemisinin and Derivatives Sales YoY (2021-2032) & (Tons) Figure 25. Europe Artemisinin and Derivatives Sales YoY (2021-2032) & (Tons) Figure 26. China Artemisinin and Derivatives Sales YoY (2021-2032) & (Tons) Figure 27. Asia (Excluding China) Artemisinin and Derivatives Sales YoY (2021-2032) & (Tons) Figure 28. South America, Middle East and Africa Artemisinin and Derivatives Sales YoY (2021-2032) & (Tons) Figure 29. Global Artemisinin and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Artemisinin and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Artemisinin and Derivatives Revenue Market Share by Type (2021-2032) Figure 33. Global Artemisinin and Derivatives Sales Market Share by Type (2021-2032) Figure 34. Global Artemisinin and Derivatives Revenue Market Share by Application (2021-2032) Figure 35. Global Artemisinin and Derivatives Sales Market Share by Application (2021-2032) Figure 36. North America Artemisinin and Derivatives Revenue Share by Type (2021-2032) Figure 37. North America Artemisinin and Derivatives Sales Share by Type (2021-2032) Figure 38. North America Artemisinin and Derivatives Revenue Share by Application (2021-2032) Figure 39. North America Artemisinin and Derivatives Sales Share by Application (2021-2032) Figure 40. North America Artemisinin and Derivatives Revenue Share by Country (2021-2032) Figure 41. North America Artemisinin and Derivatives Sales Share by Country (2021-2032) Figure 42. Europe Artemisinin and Derivatives Revenue Share by Type (2021-2032) Figure 43. Europe Artemisinin and Derivatives Sales Share by Type (2021-2032) Figure 44. Europe Artemisinin and Derivatives Revenue Share by Application (2021-2032) Figure 45. Europe Artemisinin and Derivatives Sales Share by Application (2021-2032) Figure 46. Europe Artemisinin and Derivatives Revenue Share by Country (2021-2032) Figure 47. Europe Artemisinin and Derivatives Sales Share by Country (2021-2032) Figure 48. China Artemisinin and Derivatives Revenue Share by Type (2021-2032) Figure 49. China Artemisinin and Derivatives Sales Share by Type (2021-2032) Figure 50. China Artemisinin and Derivatives Revenue Share by Application (2021-2032) Figure 51. China Artemisinin and Derivatives Sales Share by Application (2021-2032) Figure 52. Asia Artemisinin and Derivatives Revenue Share by Type (2021-2032) Figure 53. Asia Artemisinin and Derivatives Sales Share by Type (2021-2032) Figure 54. Asia Artemisinin and Derivatives Revenue Share by Application (2021-2032) Figure 55. Asia Artemisinin and Derivatives Sales Share by Application (2021-2032) Figure 56. Asia Artemisinin and Derivatives Revenue Share by Country (2021-2032) Figure 57. Asia Artemisinin and Derivatives Sales Share by Country (2021-2032) Figure 58. SAMEA Artemisinin and Derivatives Revenue Share by Type (2021-2032) Figure 59. SAMEA Artemisinin and Derivatives Sales Share by Type (2021-2032) Figure 60. SAMEA Artemisinin and Derivatives Revenue Share by Application (2021-2032) Figure 61. SAMEA Artemisinin and Derivatives Sales Share by Application (2021-2032) Figure 62. SAMEA Artemisinin and Derivatives Revenue Share by Country (2021-2032) Figure 63. SAMEA Artemisinin and Derivatives Sales Share by Country (2021-2032) Figure 64. Artemisinin and Derivatives Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Artemisinin and Derivatives Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Artemether
  • Artesunate
  • Artemisinin
  • Dihydroartemisinin
Applications
  • Antitumor and Anti-inflammatory Drugs
  • Antimalarial Drugs
Companies covered
  • Ipca Laboratories
  • Guilin Nantang Pharmaceutical
  • KPC Pharmaceuticals
  • Chongqing Kerui Nanhai Pharmaceutical
  • Sichuan Xieli Pharmaceutical
  • Cerata Pharmaceuticals
  • Aqre Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artemisinin and Derivatives Market by Type
  3. 1.2.1 Global Artemisinin and Derivatives Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Artemether
  5. 1.2.3 Artesunate
  6. 1.2.4 Artemisinin
  7. 1.2.5 Dihydroartemisinin
  8. 1.3 Artemisinin and Derivatives Market by Application
  9. 1.3.1 Global Artemisinin and Derivatives Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Antitumor and Anti-inflammatory Drugs
  11. 1.3.3 Antimalarial Drugs
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Artemisinin and Derivatives Market Dynamics
  1. 2.1 Artemisinin and Derivatives Industry Trends
  2. 2.2 Artemisinin and Derivatives Industry Drivers
  3. 2.3 Artemisinin and Derivatives Industry Opportunities and Challenges
  4. 2.4 Artemisinin and Derivatives Industry Restraints
3 Global Artemisinin and Derivatives Production Overview
  1. 3.1 Global Artemisinin and Derivatives Production Capacity (2021-2032)
  2. 3.2 Global Artemisinin and Derivatives Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Artemisinin and Derivatives Production by Region
  4. 3.3.1 Global Artemisinin and Derivatives Production by Region (2021-2026)
  5. 3.3.2 Global Artemisinin and Derivatives Production by Region (2027-2032)
  6. 3.3.3 Global Artemisinin and Derivatives Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Artemisinin and Derivatives Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Artemisinin and Derivatives Revenue by Region
  3. 4.2.1 Global Artemisinin and Derivatives Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Artemisinin and Derivatives Revenue by Region (2021-2026)
  5. 4.2.3 Global Artemisinin and Derivatives Revenue by Region (2027-2032)
  6. 4.2.4 Global Artemisinin and Derivatives Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Artemisinin and Derivatives Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Artemisinin and Derivatives Sales by Region
  9. 4.4.1 Global Artemisinin and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Artemisinin and Derivatives Sales by Region (2021-2026)
  11. 4.4.3 Global Artemisinin and Derivatives Sales by Region (2027-2032)
  12. 4.4.4 Global Artemisinin and Derivatives Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Artemisinin and Derivatives Revenue by Manufacturers
  2. 5.1.1 Global Artemisinin and Derivatives Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Artemisinin and Derivatives Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Artemisinin and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Artemisinin and Derivatives Sales by Manufacturers
  6. 5.2.1 Global Artemisinin and Derivatives Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Artemisinin and Derivatives Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Artemisinin and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Artemisinin and Derivatives Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Artemisinin and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Artemisinin and Derivatives Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Artemisinin and Derivatives Manufacturers, Product Type & Application
  13. 5.7 Global Artemisinin and Derivatives Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Artemisinin and Derivatives Market CR5 and HHI
  16. 5.8.2 2025 Artemisinin and Derivatives Tier 1, Tier 2, and Tier 3
6 Artemisinin and Derivatives Market by Type
  1. 6.1 Global Artemisinin and Derivatives Revenue by Type
  2. 6.1.1 Global Artemisinin and Derivatives Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Artemisinin and Derivatives Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Artemisinin and Derivatives Sales by Type
  5. 6.2.1 Global Artemisinin and Derivatives Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Artemisinin and Derivatives Sales Market Share by Type (2021-2032)
  7. 6.3 Global Artemisinin and Derivatives Price by Type
7 Artemisinin and Derivatives Market by Application
  1. 7.1 Global Artemisinin and Derivatives Revenue by Application
  2. 7.1.1 Global Artemisinin and Derivatives Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Artemisinin and Derivatives Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Artemisinin and Derivatives Sales by Application
  5. 7.2.1 Global Artemisinin and Derivatives Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Artemisinin and Derivatives Sales Market Share by Application (2021-2032)
  7. 7.3 Global Artemisinin and Derivatives Price by Application
8 Company Profiles
  1. 8.1 Ipca Laboratories
  2. 8.1.1 Ipca Laboratories Company Information
  3. 8.1.2 Ipca Laboratories Business Overview
  4. 8.1.3 Ipca Laboratories Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Ipca Laboratories Artemisinin and Derivatives Product Portfolio
  6. 8.1.5 Ipca Laboratories Recent Developments
  7. 8.2 Guilin Nantang Pharmaceutical
  8. 8.2.1 Guilin Nantang Pharmaceutical Company Information
  9. 8.2.2 Guilin Nantang Pharmaceutical Business Overview
  10. 8.2.3 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Guilin Nantang Pharmaceutical Artemisinin and Derivatives Product Portfolio
  12. 8.2.5 Guilin Nantang Pharmaceutical Recent Developments
  13. 8.3 KPC Pharmaceuticals
  14. 8.3.1 KPC Pharmaceuticals Company Information
  15. 8.3.2 KPC Pharmaceuticals Business Overview
  16. 8.3.3 KPC Pharmaceuticals Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 KPC Pharmaceuticals Artemisinin and Derivatives Product Portfolio
  18. 8.3.5 KPC Pharmaceuticals Recent Developments
  19. 8.4 Chongqing Kerui Nanhai Pharmaceutical
  20. 8.4.1 Chongqing Kerui Nanhai Pharmaceutical Company Information
  21. 8.4.2 Chongqing Kerui Nanhai Pharmaceutical Business Overview
  22. 8.4.3 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Chongqing Kerui Nanhai Pharmaceutical Artemisinin and Derivatives Product Portfolio
  24. 8.4.5 Chongqing Kerui Nanhai Pharmaceutical Recent Developments
  25. 8.5 Sichuan Xieli Pharmaceutical
  26. 8.5.1 Sichuan Xieli Pharmaceutical Company Information
  27. 8.5.2 Sichuan Xieli Pharmaceutical Business Overview
  28. 8.5.3 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Sichuan Xieli Pharmaceutical Artemisinin and Derivatives Product Portfolio
  30. 8.5.5 Sichuan Xieli Pharmaceutical Recent Developments
  31. 8.6 Cerata Pharmaceuticals
  32. 8.6.1 Cerata Pharmaceuticals Company Information
  33. 8.6.2 Cerata Pharmaceuticals Business Overview
  34. 8.6.3 Cerata Pharmaceuticals Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Cerata Pharmaceuticals Artemisinin and Derivatives Product Portfolio
  36. 8.6.5 Cerata Pharmaceuticals Recent Developments
  37. 8.7 Aqre Group
  38. 8.7.1 Aqre Group Company Information
  39. 8.7.2 Aqre Group Business Overview
  40. 8.7.3 Aqre Group Artemisinin and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Aqre Group Artemisinin and Derivatives Product Portfolio
  42. 8.7.5 Aqre Group Recent Developments
9 North America
  1. 9.1 North America Artemisinin and Derivatives Market Size by Type
  2. 9.1.1 North America Artemisinin and Derivatives Revenue by Type (2021-2032)
  3. 9.1.2 North America Artemisinin and Derivatives Sales by Type (2021-2032)
  4. 9.1.3 North America Artemisinin and Derivatives Price by Type (2021-2032)
  5. 9.2 North America Artemisinin and Derivatives Market Size by Application
  6. 9.2.1 North America Artemisinin and Derivatives Revenue by Application (2021-2032)
  7. 9.2.2 North America Artemisinin and Derivatives Sales by Application (2021-2032)
  8. 9.2.3 North America Artemisinin and Derivatives Price by Application (2021-2032)
  9. 9.3 North America Artemisinin and Derivatives Market Size by Country
  10. 9.3.1 North America Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Artemisinin and Derivatives Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Artemisinin and Derivatives Market Size by Type
  2. 10.1.1 Europe Artemisinin and Derivatives Revenue by Type (2021-2032)
  3. 10.1.2 Europe Artemisinin and Derivatives Sales by Type (2021-2032)
  4. 10.1.3 Europe Artemisinin and Derivatives Price by Type (2021-2032)
  5. 10.2 Europe Artemisinin and Derivatives Market Size by Application
  6. 10.2.1 Europe Artemisinin and Derivatives Revenue by Application (2021-2032)
  7. 10.2.2 Europe Artemisinin and Derivatives Sales by Application (2021-2032)
  8. 10.2.3 Europe Artemisinin and Derivatives Price by Application (2021-2032)
  9. 10.3 Europe Artemisinin and Derivatives Market Size by Country
  10. 10.3.1 Europe Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Artemisinin and Derivatives Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Artemisinin and Derivatives Market Size by Type
  2. 11.1.1 China Artemisinin and Derivatives Revenue by Type (2021-2032)
  3. 11.1.2 China Artemisinin and Derivatives Sales by Type (2021-2032)
  4. 11.1.3 China Artemisinin and Derivatives Price by Type (2021-2032)
  5. 11.2 China Artemisinin and Derivatives Market Size by Application
  6. 11.2.1 China Artemisinin and Derivatives Revenue by Application (2021-2032)
  7. 11.2.2 China Artemisinin and Derivatives Sales by Application (2021-2032)
  8. 11.2.3 China Artemisinin and Derivatives Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Artemisinin and Derivatives Market Size by Type
  2. 12.1.1 Asia Artemisinin and Derivatives Revenue by Type (2021-2032)
  3. 12.1.2 Asia Artemisinin and Derivatives Sales by Type (2021-2032)
  4. 12.1.3 Asia Artemisinin and Derivatives Price by Type (2021-2032)
  5. 12.2 Asia Artemisinin and Derivatives Market Size by Application
  6. 12.2.1 Asia Artemisinin and Derivatives Revenue by Application (2021-2032)
  7. 12.2.2 Asia Artemisinin and Derivatives Sales by Application (2021-2032)
  8. 12.2.3 Asia Artemisinin and Derivatives Price by Application (2021-2032)
  9. 12.3 Asia Artemisinin and Derivatives Market Size by Country
  10. 12.3.1 Asia Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Artemisinin and Derivatives Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Artemisinin and Derivatives Market Size by Type
  2. 13.1.1 SAMEA Artemisinin and Derivatives Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Artemisinin and Derivatives Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Artemisinin and Derivatives Price by Type (2021-2032)
  5. 13.2 SAMEA Artemisinin and Derivatives Market Size by Application
  6. 13.2.1 SAMEA Artemisinin and Derivatives Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Artemisinin and Derivatives Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Artemisinin and Derivatives Price by Application (2021-2032)
  9. 13.3 SAMEA Artemisinin and Derivatives Market Size by Country
  10. 13.3.1 SAMEA Artemisinin and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Artemisinin and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Artemisinin and Derivatives Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Artemisinin and Derivatives Value Chain Analysis
  2. 14.1.1 Artemisinin and Derivatives Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Artemisinin and Derivatives Production Mode & Process
  6. 14.2 Artemisinin and Derivatives Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Artemisinin and Derivatives Distributors
  9. 14.2.3 Artemisinin and Derivatives Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst